Drugplain

REFRESH TEARS

Carboxymethylcellulose sodium · KIT · Allergan, Inc.

1 Recall on Record
Plain English

Refresh Tears is an over-the-counter eye drop product containing carboxymethylcellulose sodium that helps relieve dry eye symptoms by lubricating and moisturizing the eyes. It is used to provide temporary comfort for irritated, dry eyes.

Key Facts

Brand Name
REFRESH TEARS
Generic Name
Carboxymethylcellulose sodium
NDC Code (Product)
0023-0795
Manufacturer
Allergan, Inc.
Dosage Form
KIT
Marketing Status
Application #
M018
Marketing Start
01/01/2000

Recall History

1 Recall on Record
Class II04/03/2017

Cell Distributors

Labeling: Not elsewhere classified; product labeling lacks a NDC number, net weight information and does not contain the Drug Facts Panel.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective996 reports
macular degeneration834 reports
off label use428 reports
eye pain404 reports
eye irritation392 reports
nausea389 reports
pain311 reports
headache291 reports
weight decreased286 reports
malaise279 reports

Frequently Asked Questions

What is REFRESH TEARS used for?

Refresh Tears is an over-the-counter eye drop product containing carboxymethylcellulose sodium that helps relieve dry eye symptoms by lubricating and moisturizing the eyes. It is used to provide temporary comfort for irritated, dry eyes.

Is REFRESH TEARS a controlled substance?

REFRESH TEARS is not classified as a controlled substance by the DEA.

What is the generic name for REFRESH TEARS?

The generic name for REFRESH TEARS is Carboxymethylcellulose sodium. There are 12 other brand versions of Carboxymethylcellulose sodium.

What is the NDC code for REFRESH TEARS ?

The NDC (National Drug Code) for REFRESH TEARS is 0023-0795, listed by Allergan, Inc..

Product NDC

0023-0795

Package NDC

0023-0795-65

Other Carboxymethylcellulose Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)